Valuation: Haleon plc

Market Cap 31.53B 43.01B 36.83B 34.36B 59.24B 4,115B 60.41B 408B 159B 2,062B 161B 158B 6,828B P/E 2026 *
18.6x
P/E 2027 * 16.4x
Enterprise Value 38.39B 52.37B 44.84B 41.84B 72.14B 5,011B 73.56B 496B 193B 2,512B 197B 192B 8,315B EV / Sales 2026 *
3.37x
EV / Sales 2027 * 3.2x
Free-Float
98.48%
Yield 2026 *
2.26%
Yield 2027 * 2.51%
1 day+0.74%
1 week+0.56%
Current month-0.94%
1 month-2.99%
3 months+5.48%
6 months-12.11%
Current year-3.98%
1 week 348.8
Extreme 348.8
362.3
1 month 348.8
Extreme 348.8
384.2
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
2/12/26 Free

General Counsel

31 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.56%+0.56%-2.52%+11.82% 42.9B
-1.32%+4.73%+79.48%+130.19% 1,141B
-1.09%+3.21%+51.26%+61.64% 659B
-0.43%+5.64%+26.68%+76.45% 470B
+1.20%+2.62%+41.69%+46.21% 366B
-0.61%+2.10%+23.43%+40.38% 302B
+0.32%+3.25%+0.94%+13.25% 254B
-1.55%+4.21%+46.88%+67.02% 239B
-1.10%-0.70%-14.31%-53.04% 207B
-1.37%+5.41%+22.65%+91.76% 183B
Average -0.55%+3.64%+27.62%+48.57% 386.39B
Weighted average by Cap. -0.77%+4.26%+44.49%+72.46%

Financials

2026 *2027 *
Net sales 11.39B 15.54B 13.31B 12.42B 21.41B 1,487B 21.83B 147B 57.42B 745B 58.36B 57.09B 2,467B 11.87B 16.2B 13.87B 12.94B 22.31B 1,550B 22.75B 154B 59.84B 777B 60.82B 59.5B 2,572B
Net income 1.7B 2.31B 1.98B 1.85B 3.19B 221B 3.25B 21.94B 8.55B 111B 8.69B 8.5B 368B 1.92B 2.62B 2.24B 2.09B 3.61B 251B 3.68B 24.83B 9.68B 126B 9.84B 9.62B 416B
Net Debt 6.86B 9.36B 8.02B 7.48B 12.9B 896B 13.15B 88.75B 34.6B 449B 35.16B 34.4B 1,487B 6.42B 8.76B 7.5B 7B 12.07B 839B 12.31B 83.06B 32.38B 420B 32.91B 32.19B 1,391B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (31.4%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - pain relief medicines (23.2%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - respiratory medicines (17%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (15.3%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.; - medicines for digestive health (8.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - other (4.2%). Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.6%), North America (35.1%), and Asia/Pacific (23.3%).
Employees
24,535
Date Price Change Volume
26-08-20 GBX 359.90 +0.56% 16,006,700
26-08-19 GBX 357.90 +0.65% 23,666,803
26-08-18 GBX 355.60 +1.54% 21,852,263
26-08-17 GBX 350.20 -1.52% 11,334,933
26-08-14 GBX 355.60 -0.64% 6,422,346
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.579GBP
Average target price
4.208GBP
Spread / Average Target
+17.58%

Quarterly revenue - Rate of surprise